Literature DB >> 21888852

Cytokines in acute kidney injury (AKI).

D W Lee1, S Faubel, C L Edelstein.   

Abstract

In acute kidney injury (AKI), many cytokines are released by leukocytes and renal tubular cells in the injured kidney and are important components of both the initiation and extension of inflammation. Cytokines are 1) produced by the kidney and mediate AKI, 2) produced by the kidney, released into the blood or urine and serve as biomarkers of AKI, and 3) produced by the kidney or other organs in AKI and mediate or protect against distant organ injury. Further understanding of the role of cytokines in AKI may result in therapeutic approaches like cytokine inhibition that may reduce the degree of kidney injury itself, as well as deleterious effects of kidney injury on other organs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888852     DOI: 10.5414/cn106921

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  31 in total

1.  Depletion of macrophages and dendritic cells in ischemic acute kidney injury.

Authors:  Lawrence Lu; Sarah Faubel; Zhibin He; Ana Andres Hernando; Alkesh Jani; Ross Kedl; Charles L Edelstein
Journal:  Am J Nephrol       Date:  2012-01-25       Impact factor: 3.754

2.  Retrospective Analysis of Mortality Cases in Advanced and Metastatic Solid Tumors With Concurrent Prerenal Azotemia.

Authors:  Tzu-Yao Liao; Chuang-Chi Liaw
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.

Authors:  Silvia Pastori; Grazia Maria Virzì; Alessandra Brocca; Massimo de Cal; Anna Clementi; Giorgio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-02-11       Impact factor: 2.041

4.  NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury.

Authors:  Hyun-Jung Kim; Dong Won Lee; Kameswaran Ravichandran; Daniel O Keys; Ali Akcay; Quocan Nguyen; Zhibin He; Alkesh Jani; Danica Ljubanovic; Charles L Edelstein
Journal:  J Pharmacol Exp Ther       Date:  2013-07-05       Impact factor: 4.030

5.  Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury.

Authors:  Paweena Susantitaphong; Mary C Perianayagam; Hocine Tighiouart; Orfeas Liangos; Joseph V Bonventre; Bertrand L Jaber
Journal:  Nephron Clin Pract       Date:  2013-06-21

Review 6.  Inflammasomes in the Pathophysiology of Kidney Diseases.

Authors:  Humaira Masood; Ruochen Che; Aihua Zhang
Journal:  Kidney Dis (Basel)       Date:  2015-09-04

7.  Assessment of tumor necrosis factor alpha polymorphism TNF-α-238 (rs 361525) as a risk factor for development of acute kidney injury in critically ill patients.

Authors:  Sameer H Fatani; Abeer Ahmed ALrefai; Hiba S Al-Amodi; Hala F Kamel; Kasem Al-Khatieb; Hamdy Bader
Journal:  Mol Biol Rep       Date:  2018-07-05       Impact factor: 2.316

8.  C-reactive protein exacerbates renal ischemia-reperfusion injury.

Authors:  Melissa A Pegues; Mark A McCrory; Abolfazl Zarjou; Alexander J Szalai
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-27

9.  Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Joseph C Gigliotti; Hong Ye; Jacqueline Miller; Diane L Rosin; Peter I Lobo; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 10.121

10.  The Effect of Autophagy on Inflammation Cytokines in Renal Ischemia/Reperfusion Injury.

Authors:  Haibin Ling; Hongguang Chen; Miao Wei; Xiaoyin Meng; Yonghao Yu; Keliang Xie
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.